AIM ImmunoTech Inc

ASE:AIM   1:03:11 PM EDT
0.96
+0.06 (+6.34%)
Earnings Announcements

Aim Immunotech Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update

Published: 03/31/2022 20:57 GMT
AIM ImmunoTech Inc (AIM) - Aim Immunotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update.
Revenue is expected to be $0.14 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $0.15 Million
Next Quarter EPS Guidance is expected to be -$0.08

More details on our Analysts Page.